In a traditional Chinese medicine industry with a good policy as a whole, why do Chinese medicine de

In 2022, China has made it clear that it will support the development of traditional Chinese medicine, and will actively promote the comprehensive reform of traditional Chinese medicine, but many domestic traditional Chinese medicine decoction factories are looking for opportunities for cooperation and transfer, and many people also feel very puzzled. Professionals said that this situation has some relationship with various factors, such as insufficient enterprise innovation, backward technology, industry involution, changes in the market environment, and urgent need for transformation.

It is usually difficult for Chinese medicine decoction pieces factories to sell, although there are also cases of ** acquisitions, but this situation is relatively rare. Some small and medium-sized Chinese medicine decoction pieces factories are facing great pressure, with the channel being squeezed, the increase in testing costs and the slow collection of various reasons, resulting in the decoction pieces factory in a state of loss, and did not make money, which also made many people give up the Chinese medicine decoction piece industry. In 2020, the latest version of the Chinese Pharmacopoeia was released in China, which added testing for certain substances, which also led to an increase in the cost of testing.

If the Chinese medicine decoction piece factory wants to sell its products, then it needs to comply with the relevant national regulations, and it also needs to meet the corresponding regulatory requirements, and it needs to invest a lot of money in the monitoring process, which also leads to the continuous reduction of the profits of the Chinese medicine decoction piece factory. Some small enterprises are also facing cost pressure, mainly reflected in the process of traditional Chinese medicine procurement, and some small enterprises do not have their own planting bases, so they need to purchase their own. If you want to purchase low-cost Chinese herbal medicines, you need internal channels, and if you want to buy high-quality Chinese herbal medicines, you also need to spend a relatively large cost.

If some companies do not have an advantage in the market, then it is difficult to obtain excellent sales channels, and slow payment collection is also one of the major problems. The sales channels of many TCM decoction factories are outpatient clinics, hospitals and pharmacies, but the competitive pressure is too great, even if the problem of sales channels is solved, it cannot effectively solve the problem of slow payment collection. If the capital chain of some small and medium-sized enterprises is broken, it will lead to the failure of business, and it will also make businesses suffer great losses.

It must be that the technology is relatively backward, the cost of testing is relatively high, the pressure on all aspects is relatively large, and the flow of funds is relatively small, so it has lost the ability to compete in the market.

Because after the new pharmacopoeia came out, the cost of testing increased, and the industry's technical advantages and sales channel advantages declined, resulting in many small factories making ends meet and in a state of loss.

Because of poor management and the epidemic in recent years, the Chinese medicine factory has a shortage of funds, and the production cannot be maintained.

Answer] :d production of traditional Chinese medicine decoction pieces must hold the "Drug Production License" and "Pharmaceutical Code Distribution GMP Certificate"; Chinese herbal medicines must be used as starting materials, Chinese herbal medicines that meet the medicinal standards must be used, and the origin of medicinal materials should be fixed as much as possible; It is necessary to strictly implement the national drug standards and local specifications and process regulations for the processing of silver return traditional Chinese medicine missed mold banquet pieces. It is strictly forbidden for manufacturers to purchase semi-finished or finished Chinese medicine decoction pieces for sub-packaging or changing packaging labels.

The production of traditional Chinese medicine decoction pieces is to purchase and produce their own decoction pieces, and the processing of traditional Chinese medicine decoction pieces is to entrust the factory with medicinal materials provided by others.

Chinese herbal decoction pieces are Chinese herbal medicines that can be directly used in the clinical practice of Chinese medicine after processing and processing according to the theory of Chinese medicine and the processing method of Chinese medicine. This concept shows that there is no absolute boundary between Chinese herbal medicines and Chinese herbal decoction pieces, and Chinese herbal decoction pieces include some traditional Chinese medicine slices (including cut sections, blocks, and petals) processed by the place of origin, original herbal decoction pieces, and decoction pieces that have been cut (on the basis of processing at the place of origin) and burned by gun. The first two types should be regarded as Chinese herbal medicines in management, but they are only understood as decoction pieces in formulations and preparations according to the theory of traditional Chinese medicine.

The concept of decoction pieces in the management sense should be understood as: "according to the needs of blending or preparation, the finished product of further cutting and roasting of the net medicinal materials processed by the place of origin is called traditional Chinese medicine decoction pieces".

Flow chart of the net production process of traditional Chinese medicine decoction pieces.

The more famous ones I know are Guizhou Xianlong Pharmaceutical and Kangmei Pharmaceutical, both of which are relatively large manufacturers of traditional Chinese medicine decoction pieces. Here's a brief introduction to them, I hope it can help you.

Kangmei Pharmaceutical Co., Ltd. is a large-scale pharmaceutical listed company and a national key high-tech enterprise focusing on the production of medicinal decoction pieces, chemical raw materials and chemical preparations, and integrating drug research and development, production and marketing of drugs and medical devices.

Guizhou Xianlong Pharmaceutical Co., Ltd. is located in the industrial park of Meitan County, Guizhou Province, located in the Yunnan-Guizhou Plateau, with a unique altitude climate that breeds rich traditional Chinese medicine resources.

The current policy stipulates that agricultural products are within the scope of low value-added tax rates, and Chinese herbal medicines, including traditional Chinese medicine decoction pieces, are within the scope of agricultural products, and a tax rate of 13% is applicable. General VAT taxpayers who produce proprietary Chinese medicines purchase tax-free Chinese herbal medicines sold by agricultural producers, or Chinese herbal medicines purchased by small-scale taxpayers, and the input VAT credit shall be calculated according to the purchase price and the deduction rate of 13%; The input tax shall be deducted at the rate of 13% for the purchase of Chinese herbal medicines purchased by general VAT taxpayers of medicinal materials business households.

Proprietary Chinese medicines produced by proprietary Chinese medicine manufacturers are taxed at a VAT rate of 17%. This situation of low input tax rate and high output tax rate is unreasonable.

At present, the state encourages the development of traditional Chinese medicine modernization projects, including the GAP planting of Chinese herbal medicines, the protection and comprehensive utilization of Chinese herbal medicine resources, the research and production of Chinese herbal medicine decoction pieces formula granules, the GMP production of Chinese herbal medicines and the improvement of production technology and equipment, the research and development of new Chinese patent medicines and the secondary development of famous and high-quality products.

The main factor of high production cost is the high level of raw materials, especially the high level of various Chinese herbal medicines, which is the main raw material of Chinese patent medicine, which affects the enthusiasm of enterprises to develop traditional Chinese medicine projects and restricts the development of enterprises.

At present, what can be done is to increase the VAT rate of Chinese herbal medicines, and the general VAT taxpayers who produce Chinese patent medicines and the general VAT taxpayers of Chinese herbal medicine business enterprises purchase tax-free Chinese herbal medicines sold by agricultural producers, or Chinese herbal medicines purchased by small-scale taxpayers, and calculate the input tax deduction according to the purchase price and the deduction rate of 17%; The input tax shall be deducted at the rate of 17% for the Chinese herbal medicines purchased by the general VAT taxpayers of the production of proprietary Chinese medicines from the general VAT taxpayers of the Chinese herbal medicine trading enterprises.

After the adjustment, it can not only reduce part of the tax burden for Chinese patent medicine production enterprises, improve the enthusiasm of enterprises to develop and produce Chinese patent medicines, but also encourage farmers to plant and produce Chinese herbal medicines.

Nanning Shengyuan Traditional Chinese Medicine Decoction Pieces Co., Ltd. was established in March 1999. Over the past few years, with the strong support of departments at all levels and users in the autonomous region and city, the company has been growing and developing.

The company was established in October 2006 in Guangxi Food and Drug Administration, after more than a year of design, planning and construction. At the end of 2007, the second production base was opened in Ertang Industrial Park, Qingxiu District, Nanning City, No. 28 Yongbin Road (the original No. 2 Yongbin Road plant was retained), and on December 12, 2007, it passed the GMP on-site certification at one time (the original Yongbin Road No. 2 plant also passed the GMP on-site certification). It became the first Chinese medicine decoction piece manufacturer in the capital of Guangxi to pass GMP on-site certification.

Its production and operation scope is: purification, cutting, frying, broiling, steaming and calcination of traditional Chinese medicine decoction pieces (including toxic Chinese medicine decoction pieces).

The company is built according to GMP standards, the factory covers an area of 6,000 square meters, 1,000 square meters of green area, construction area of 3,220 square meters, production workshop and storage area of 1,750 square meters, respectively, set up a net workshop, washing and infiltration workshop, cutting workshop, calcining workshop, crushing workshop, frying workshop, drying workshop, screening workshop, packaging workshop, toxic medicinal materials production workshop, each workshop is equipped with corresponding modern production equipment. The warehouse is set up with raw material warehouse and finished product warehouse, and the warehouse is set up with room temperature warehouse and cool warehouse respectively. The annual production of traditional Chinese medicine decoction pieces can reach more than 1,000 tons.

The variety is complete and the quality is reliable. The products have formed a sales body with Nanning as the center, Guilin, Liuzhou, Baise, Wuzhou, Beihai, Hechi, Fangcheng, Pingxiang and Qinzhou as outlets.

The comprehensive inspection office building has a construction area of 295 square meters, with a laboratory, a precision instrument room, a product sample room, and a Chinese herbal medicine specimen room, which implements effective control over the quality of products

The company has a high-quality workforce, the company has 86 employees, 26 pharmacy and various technical personnel, accounting for 30 of the total number of employees The company strictly produces in accordance with GMP standards, adheres to the integrity-based, win-win pursuit, and ultimately achieves the goal of harmonious development between enterprises and customers!

Welcome people from all walks of life in the pharmaceutical industry to patronize and inquire!

We will work together with people from all walks of life to develop and carry forward the treasure of our motherland - traditional Chinese medicine, and make our due contribution to it.

The national collection of Chinese patent medicine is coming, and it will face the phenomenon of reshuffling, and there will definitely be a different development path in the future. As long as it is successful, then Chinese patent medicine will become a kind of normalization. In this process, the relevant drug data will definitely be reviewed to a certain extent, and the coverage will definitely be very extensive.

Each pharmacy has its own unique brand, which will be supplemented to the patient at this time. No matter what kind of medicine you use, you have to go to the hospital to buy it. <>

The belated centralized procurement of proprietary Chinese medicines will cause some medical institutions to close down, and there is no need to use these means to sell more money. Because they will ensure the quality of their products when they are purchasing, and they will also implement the unity of high quality standards. Research its cost so that the recipe is unique.

Medical institutions generally do not obtain these formulas, even if they spend a lot of money. Patients must be allowed to buy good things in order to have a certain protection for themselves. <>

The company will pay in cash to various groups for drug procurement, which will generally reach 2.9 billion. As long as the transaction can be successful, it will definitely open the company bigger and bigger, so that the profit method can be further improved. Otherwise, the management ability will definitely become weaker and weaker.

In the process of centralized procurement, we must take a look at the strength of the company and what the background behind it is. As long as you can meet the requirements, you can choose to make a purchase. <>

In general, don't buy some cheaper drugs on the Internet, you are likely to fall into the trap of others. The Chinese herbal medicine market is about to change, which means that it will be officially incorporated into the hospital. Centralized procurement can never be abandoned by hospitals, and this ancient prescription must be passed on.

Some diseases that cannot be cured by Western medicine have a good space for Chinese medicine. Everyone should be responsible for themselves, and don't hurt themselves by being cheap.

While qualified companies should do well, they have the ability to make themselves strong.

In the future, it will definitely be combined with Western medicine, because the combination of Chinese and Western medicine will always be the key medical program.

This initiative of the Chinese medicine industry is also to better regulate the Chinese medicine market and better serve consumers. Next, it needs to meet the standards set by the state before it can be listed.

The country is preparing to collect Chinese patent medicines, and the Chinese medicine industry is facing a reshuffle, and pharmaceutical companies should respond in this way, first of all, to comply with a national policy. Secondly, you can find some of your own work from an angle that you can break through. Finally, it is necessary to actively transform and better serve the country.

The country is ready to collect Chinese patent medicines, the Chinese medicine industry is facing a reshuffle, pharmaceutical companies should respond in this way, first of all, that is, to know how to conform to the pace of national development, only in this way will not let their enterprises suffer from some unnecessary problems, only in line with the part of the country's development can we better find a direction for their own development. <>

The country is ready to collect Chinese patent medicines, the traditional Chinese medicine industry is facing a reshuffle, pharmaceutical companies should respond in this way, that is, to know how to find some breakthroughs, can provide a breakthrough for their own development, only in this way can they make their own enterprises have a chance to survive, if they can not find a breakthrough in the redevelopment of enterprises, it is likely to face the phenomenon of closing the door of the enterprise, so the most important thing should be to find a breakthrough in their own development. <>

The country is ready to collect Chinese patent medicines, the Chinese medicine industry is facing a reshuffle, pharmaceutical companies should face it like this, then you are to actively transform, transform one of their own functions, now most of the country's development is in need of some service-oriented enterprises, then for to get up, the most important thing should also be to turn to a service-oriented direction, in order to better develop, their own adaptation to a response of the country. <>

In short, the country is ready to collect Chinese patent medicines, and the traditional Chinese medicine industry is facing a reshuffle, so pharmaceutical companies should first comply with the pace of development of the country, secondly, to find a breakthrough in their own development, and finally to let themselves know how to transform positive energy and better serve the development of the country, so as to be able to survive.